Erste Asset Management Adjusts Portfolio, Boosting Stakes While Trimming Citigroup

Erste Asset Management GmbH reported new SEC 13F filings showing changes across several large U.S. stocks, increasing positions in Natera, Ecolab, TJX Companies, and Tapestry while trimming its stake in Citigroup. In Natera, Erste added shares to hold 126,500 and the company also reported insider selling by director Roelof Botha. Erste boosted its Ecolab stake to 163,731 shares, adding alongside other major funds that adjusted their own holdings. The firm also expanded its apparel and home-fashions exposure by raising its TJX stake by roughly half, lifting it to 909,977 shares, and modestly increased Tapestry to 993,400 shares. Overall, the updates underscore ongoing institutional activity across healthcare, industrials, consumer retail, and financial services, as reflected in the breadth of concurrent hedge-fund and asset-manager changes.
In Natera, director Roelof Botha sold 78,000 shares at an average price of $220.31 in a transaction dated Monday, June 1, and “Following the completion of the transaction, the director directly owned 1,076,198 shares.”
Ecolab saw large moves by other major institutions alongside Erste’s increase—JPMorgan Chase & Co. “grew its position… by 63.1%,” adding 4,110,472 shares to own 10,622,035, while Vanguard grew by 0.5% to 25,327,693 shares.
For TJX, Erste’s update wasn’t just a partial increase: it said the stake accounts for “about 1.2% of Erste Asset Management GmbH’s portfolio,” making TJX its “17th largest position,” after Erste added 310,927 shares to reach 909,977 (a “51.9%” increase).
Tapestry also drew fresh external research coverage in the same reporting cycle—BTIG Research “restated a ‘buy’ rating and set a $180.00 price objective” on May 8, according to the article.
For Citigroup, multiple analysts reiterated bullish stances while Erste trimmed its position: Jefferies initiated coverage with a “buy” rating and a $135.00 price target, JPMorgan set an “overweight” rating with a raised target to $135.50, and Barclays raised its target to $154 and kept an “overweight” rating.
Publishers
20
Articles
7
Reach
27
Major Stake Adjustments